SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-015088
Filing Date
2024-05-31
Accepted
2024-05-31 18:00:18
Documents
2
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 form4-05312024_060514.html 4  
1 form4-05312024_060514.xml 4 10257
2 ex24-05312024_060514.htm EX-24 3506
  Complete submission text file 0001415889-24-015088.txt   15249
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
GAROFALO ELIZABETH A. (Reporting) CIK: 0001826361 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 241011309